Presents results of an international, multicenter study that examined the degree to which the braintype natriuretic peptide (BNP) enhances clinical judgment in diagnosing congestive heart failure (CHF). Action of the peptides in inhibiting the rennin-angiotensin system and the endothelin pathway; ...
B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure Finding a simple blood test to aid in the diagnosis and treatment of patients with congestive heart failure could have a favorable impact on the costs asso... A Maisel - 《Journal of Cardiac Failur...
Lab Test (1) Tables (2) Videos (3)Heart failure develops when the contracting action or the relaxing action of the heart is inadequate, typically because the heart muscle is weak, stiff, or both. Many disorders that affect the heart can cause heart failure. Most people have no symptoms...
Lab Test (1) Tables (2) Videos (3)Heart failure develops when the contracting action or the relaxing action of the heart is inadequate, typically because the heart muscle is weak, stiff, or both. Many disorders that affect the heart can cause heart failure. Most people have no symptoms ...
heart muscle and is characterized by enlargement and dilation of one or both ventricles along with impaired contractility, which is defined as LVEF <40% [6]. The patient was discharged after 1 month (NYHA class III; BNP, 360 pg/mL) with a post-discharge treatment regimen including carvedilol...
We visually inspected DBS but did not formally test for possible variations in blood volumes, which may have influenced our results; just as different DBS sampling methods might in other settings.57,58 Subgroup analyses of specific CHD types was limited to cases with coarctation of the aorta due...
congestive heart failure, reduced left ventricular ejection fraction, or diastolic dysfunction). Similarly, elevated systolic blood pressures near the time of dyspnea onset, cardiomegaly, and/or increased circulating levels of brain natriuretic peptide (BNP) or N-terminal (NT)-pro-BNP support a ...
Nakao et al (2007)22 Haemodialysis for at least 6 months; BNP >200 pg/mL; hANP <150 pg/mL; left ventricular hypertrophy Carvedilol 20 mg/day Matched placebo Randomised, open-label, placebo-controlled trial Myocardial infarction, stroke, hospital admission for heart failure, peripheral vascular ...
NT-proBNP resulted to be a stronger prognostic marker than ECG and its dosage has been proposed as first test for the CV stratification instead of ECG [103]. Predictive value of elevated BNP levels on mortality has been tested also in several clinical scenarios different from CVD, such as chr...
Immunoglobulin light chain amyloidosis (AL) should be considered in any patient that presents to a cancer care provider with nephrotic range proteinuria, heart failure with preserved ejection fraction, non-diabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea. More importantly, patients being...